SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN is experiencing significant community momentum as holders emphasize their commitment to long-term growth through voluntary supply locks and consistent daily engagement. Investors are drawn to its positioning as a community-driven project on Solana, contrasting its stable, collaborative atmosphere with the volatility and short-term nature of other meme coin markets.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as the community highlights its evolution into a multi-chain, permissionless brand driven by organic growth and tangible IRL products like energy drinks and spices. Investors are actively discussing their long-term conviction, frequently sharing experiences from the project's various business initiatives and praising the project's consistent, grassroots approach to expansion.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased market attention driven by its recent integration into post-quantum cryptographic standards and ongoing discussions regarding its status as a digital commodity rather than a security. Community sentiment remains polarized, with active debates centered on long-term institutional adoption potential, concerns over foundation governance, and the opportunity for accumulation amidst ongoing price volatility.

Fidelity Covington Trust - Fidelity MSCI Communication Services Index ETF

Fidelity MSCI Communication Services Index ETF

FCOM is currently garnering attention as investors weigh its exposure to major communication and tech heavyweights against broader debates regarding the influence of Hollywood and AI on market behavior. The community is actively discussing the fund's role as a long-term investment vehicle for those seeking diversified access to the evolving communications and media landscape.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos is experiencing heavy debate among community members as investors weigh potential technical upgrades and tokenomics redesigns against persistent concerns about its long-term price performance and ecosystem sustainability. While some stakeholders remain bullish on its role as an interoperable 'Internet of Blockchains' and its attractive staking rewards, others are actively shorting the asset, citing a lack of growth compared to other major crypto projects.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as investors weigh strong financial results and strategic growth, including the acquisition of SkyWater Technology, against significant short interest and concerns regarding share dilution from ongoing resale filings. The community is actively debating the company's long-term commercial potential and its positioning within the rapidly evolving quantum sector compared to emerging competitors.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing high volatility and intense community discussion following the high-profile firing of Attorney General Pam Bondi. Investors and political observers are actively debating the timing of this leadership change, questioning whether it signals a shift in legal strategy regarding ongoing probes or reflects internal instability within the administration.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to a positive earnings report and anticipate potential catalysts from upcoming White House meetings regarding cannabis rescheduling and CBD pilot programs. The community remains deeply divided, with bulls highlighting the company's diversification and improved fundamentals while bears point to persistent share dilution concerns and skepticism over management's long-term performance.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors react to a significant push for increased defense spending, highlighted by reports of major new procurement orders and government initiatives to modernize tactical military assets. The community is actively debating the company's long-term outlook, weighing the potential impact of expanded defense contracts against political scrutiny regarding corporate payouts and executive compensation.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is experiencing significant volatility and market attention as investors weigh a major multibillion-dollar write-down related to the company's EV production pullback and restructuring. Despite these structural charges, the stock remains a focal point for the community due to its record-setting run earlier in the year, persistent debate over the long-term viability of legacy automaker valuations, and ongoing speculation regarding capital returns like dividends and buybacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The FDA issued a complete response letter regarding the application for RP1 in combination with Nivolumab for the treatment of advanced melanoma in late July.</li><li>Following months of engagement between the company and the FDA, the company subsequently resubmitted its application in October with additional information, data and analyses.</li></ul> Shares of Replimune Group Inc (REPL) closed 11% higher on Thursday as the deadline for the U.S. Food and Drug Administration’s decision on its skin cancer therapy RP1 draws close.The FDA is slated to decide on the company’s application for RP1 in the treatment of advanced melanoma by April 10. RP1 is Replimune’s lead product candidate.<h2 class="st-heading-2">RP1’s Past Issues</h2>The FDA <a href="https://stocktwits.com/news-articles/markets/equity/replimune-sarepta-capricor-stocks-surge-after-vinay-prasad-fda-exit/choXJLOR5Cg">issued</a> a complete response letter regarding the application for RP1 in combination with Nivolumab for the treatment of advanced melanoma in late July.The agency said in the letter that it is unable to approve the application in its present form and indicated that the trial conducted by the company for the drug is not considered to be an adequate and well-controlled clinical investigation that provides substantial evidence of effectiveness.Following months of engagement between the company and the FDA, the company subsequently resubmitted its application in October with additional information, data and analyses.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around REPL stayed within the ‘bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user said that shareholders are setting up to be disappointed like the last time when RP1 was denied approval.<stembedurl>https://www.stocktwits.com/TopCharts/message/649353360</stembedurl>Yet another expressed doubts about the FDA approving the drug, opining that a fresh trial would be needed for the same.<stembedurl>https://www.stocktwits.com/Steve_TheBull_Rogers/message/649347582</stembedurl>According to data from Koyfin, five of the seven analysts covering REPL stock rate it ‘Buy’ or higher while two rate it a ‘Hold’. The 12-month average price target on the stock is $12.86, representing a potential upside of about 53%. &nbsp;<a href="https://stocktwits.com/symbol/REPL">REPL stock</a> has fallen 2% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-sbac-stock-rallying-today/cZ7UR5SRI8r">Why Is SBAC Stock Rallying Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

REPL Stock Rallies In Anticipation Of FDA Decision On Skin Cancer Drug

The FDA is slated to decide on the company’s application for RP1 in the treatment of advanced melanoma by April 10.

Equity

U.S. President Donald Trump gets out of aTesla Model S on the South Lawn of the White House on March 11, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

TSLA Stock Tumbles 5% Following Q1 Delivery Miss — Street Weighs In On Demand, Potential Discounts, AI Strategy

Tesla’s Q1 delivery numbers fell below a company-compiled analyst estimate of 365,645 deliveries.

Shares of SBA Communications Corp (SBAC) jumped 15% on Thursday following a report that the company is exploring options including sale.Bloomberg reported, citing people familiar with the matter, that the telecommunications company received preliminary takeover interest from large infrastructure funds.The company is now working with advisers to evaluate the interest, the report said, while adding that the deliberations are at an early stage.Get updates to this developing story directly on Stocktwits.

In this photo illustration, the SBA Communications Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Is SBAC Stock Rallying Today?

Bloomberg reported, citing people familiar with the matter, that SBA Communications received preliminary takeover interest from large infrastructure funds.

<ul class="summary-bullets"><li>While the trial failed its primary endpoint of significant reduction in depression severity, the drug was well tolerated and demonstrated a favorable safety profile, the company said.&nbsp;</li><li>Lipocine, however, said that it has identified signals in a post hoc analysis that could indicate a potential development path for LPCN 1154.</li><li>The company said it will preserve capital and engage with shareholders to evaluate all options available to the company going forward.</li></ul>Shares of Lipocine Inc. (LPCN) fell 78% on Thursday after the company said that its experimental drug LPCN 1154 did not bring about a significant reduction in the severity of postpartum depression in a trial.While the trial failed its primary endpoint of significant reduction in depression severity, the drug was well tolerated and demonstrated a favorable safety profile enough to support outpatient administration without the need for healthcare provider monitoring, the company said. No treatment-related severe or serious adverse events were reported and no cases of excessive sedation or loss of consciousness were observed, it added.<h2 class="st-heading-2">What’s Next For Lipocine?</h2>Lipocine, however, said that it has identified signals in a post hoc analysis that could indicate a potential development path for LPCN 1154. The company has applied for breakthrough therapy and fast track designations for LPCN 1154 in patients with postpartum depression based on the post hoc analysis results, the company said.While it waits for the FDA to get back, the company said it will preserve capital and engage with shareholders to evaluate all options available to the company going forward, including continued development of LPCN 1154, development of other product candidates, strategic transactions, partnerships, and other opportunities, it said.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around LPCN rose from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.A Stocktwits user drew focus to the company’s remaining pipeline, which includes experimental drugs for the treatment of non-alcoholic steatohepatitis, for the management of symptoms associated with cirrhosis and another for the prevention of recurrent preterm birth.<stembedurl>https://www.stocktwits.com/Boknow/message/649308142</stembedurl>Another user expressed hopes for a minor recovery after the crash. &nbsp;<stembedurl>https://www.stocktwits.com/Ruttobillions/message/649292640</stembedurl><a href="https://stocktwits.com/symbol/LPCN">LPCN stock</a> has dropped 37% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sgml-stock-soars-on-100-m-bank-guarantee-retail-says-one-last-hurdle-is-behind/cZ7xCWQRI8Z">SGML Stock Soars On $100M Bank Guarantee, Retail Says 'One Last Hurdle' Is Behind</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Lipocine is displayed on the screen of a smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

LPCN Stock Crashes 78%— Here’s Why 

Lipocine said that its experimental drug LPCN 1154 did not bring about a significant reduction in the severity of postpartum depression in a trial.

Online retailer Amazon.com Inc (AMZN) said on Thursday that it will start charging sellers a surcharge to compensate for rising oil prices.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://sellercentral.amazon.com/seller-forums/discussions/t/7cbc0233-ee5b-4359-978a-dee7cad5c6f4">said</a> in a statement that it will impose a 3.5% “fuel and logistics” surcharge later this month on sellers who use its shipping services in the U.S. and Canada.“Elevated costs in fuel and logistics have increased the cost of operating across the industry,” the company said, while adding that it absorbed the increased costs so far.The company said that it will apply the surcharge across Fulfillment by Amazon (FBA) selling program in the US and Canada as well as to Remote Fulfillment with FBA from the US into Canada, Mexico, and Brazil starting April 17. Fulfillment by Amazon (FBA) is a service where sellers send products to Amazon fulfillment centers, and Amazon handles storage, packing, shipping, and customer service. Starting May 2, the surcharge will also apply to items shipped by Amazon for merchants who sell on their own websites or through other retailers.Amazon also noted that surcharge is “meaningfully lower” than other major carriers due to its efforts to lower costs. It added that it will continue to evaluate the surcharge as conditions evolve.<h2 class="st-heading-2">Oil Prices</h2>As the U.S.-Israeli war against Iran enters its sixth week, oil prices have surged into uncharted territory, with Brent crude leaping more than 50 percent since strikes began on Feb. 28 and briefly piercing $119 a barrel before settling near $108–$112 amid fresh volatility. Iran has imposed a de-facto blockade on the Strait of Hormuz — the chokepoint for nearly one-fifth of global oil — while repeated Iranian missile and drone strikes on refineries and gas plants in the UAE, Bahrain and Qatar have further crippled energy supplies.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around AMZN stayed within the ‘neutral’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<a href="https://stocktwits.com/symbol/AMZN">AMZN stock</a> has gained 7% over the past 12 months.&nbsp;Read More:<a href="https://stocktwits.com/news-articles/markets/equity/lpcn-stock-crashes-heres-why/cZ7x6c9RI88"> LPCN Stock Crashes 78%— Here’s Why</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Amazon logo displayed on a phone screen is seen in this illustration photo taken in Krakow, Poland.

Amazon To Charge Sellers Extra In Light Of Rising Oil Prices

The company said in a statement that it will impose a 3.5% “fuel and logistics” surcharge later this month on sellers who use its shipping services.

5 Good ETFs to Buy and Hold for the Long Term

Volatility rises amid Iran tensions, but long-term investing still wins. Here are 5 ETFs to buy and hold through uncertainty and build lasting wealth.



<ul class="summary-bullets"><li>Blue Owl honored redemptions worth $988 million in the Blue Owl Credit Income Corp. fund in the first quarter, while blocking exits worth $3.2 billion.</li><li>In the smaller Blue Owl Technology Income Corp. fund, the asset manager honored redemptions worth $179 million while blocking redemptions worth $1 billion.</li><li>Blue Owl had previously allowed investors to pull 15.4% of the net assets from the Blue Owl Technology Income Corp. fund in Q4.</li></ul>Blue Owl Capital Inc. (OWL) shares tumbled more than 7% in Thursday’s opening trade after the asset manager reportedly blocked nearly $4.2 billion in investor redemptions.According to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-04-02/blue-owl-bdcs-impose-caps-after-facing-41-22-requests-to-exit">report</a>, Blue Owl honored redemptions worth $988 million in the Blue Owl Credit Income Corp. fund in the first quarter (Q1), while blocking exits worth $3.2 billion.In the smaller Blue Owl Technology Income Corp. fund, the asset manager honored redemptions worth $179 million while blocking redemptions worth $1 billion, the report stated.<h2 class="st-heading-2">Shareholders' Exit Requests Soar To Nearly 41%</h2>The report added that redemption requests soared to about 40.7% in the Blue Owl Technology Income Corp. fund in Q1, rising from 15.4% during the fourth quarter (Q4).The relative jump in the larger Blue Owl Credit Income Corp. fund was even higher, soaring to 21.9% in Q1 from 5.2% in Q4.Blue Owl had previously allowed investors to withdraw 15.4% of the net assets from the Blue Owl Technology Income Corp. fund in Q4, according to another Bloomberg report. However, the asset manager has now capped it to 5%.According to the report, Blue Owl stated that the 5% redemption cap is “in accordance with the fund structure, reflecting our commitment to balancing the interests of both tendering and remaining shareholders.”<h2 class="st-heading-2">Analysts Dismiss Concerns Of A Systemic Risk In Private Credit</h2>Analysts at ING Think dismissed concerns of a systemic risk in private credit.“Banking system exposure, both direct and indirect, appears manageable and recent analysis from the Office of Financial Research and Moody’s provides reassurance,” the firm stated in a recent note.ING Think analysts added that, given the recent news flow, they think that the continued redemption pressure across private credit funds seems unavoidable. The firm added that most funds may impose withdrawal limits.The firm also stated that AI disruption and Middle East tensions present lasting headwinds for the sector, highlighting its overexposure to software and SaaS lending.“If AI-driven disruption pushed default rates to twice Fitch's current 5.2% private credit default rate, the implications for the cost of capital would be significant,” the firm added.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/OWL">Blue Owl</a> trended in the ‘bullish’ territory at the time of writing.One user termed the company the “Lehman Brothers of 2026.”<stembedurl>https://stocktwits.com/mkt75/message/649283845</stembedurl>Another user thinks that this is a “canary in the coal mine.”<stembedurl>https://stocktwits.com/BeatingTheOdds/message/649289022</stembedurl><a href="https://stocktwits.com/symbol/OWL">OWL stock</a> is down 46% year-to-date and 62% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 15% over the past 12 months, while the Vanguard Growth Index Fund ETF (VUG) is up 16%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-slumps-as-tesla-q1-deliveries-miss-estimates/cZ7xMm3RI8g">TSLA Stock Slumps 4% As Q1 Deliveries Miss Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Blue Owl Capital logo is seen displayed on a smartphone screen

OWL Stock Sinks After Blue Owl Reportedly Blocks Nearly $4.2B In Redemptions

According to a Bloomberg report, redemption requests soared to about 40.7% in the Blue Owl Technology Income Corp. fund in Q1, rising from 15.4% during the fourth quarter.

<ul class="summary-bullets"><li>Cocrystal stated that the Fast Track designation is aimed at facilitating the development of drugs that treat serious conditions and address unmet medical needs, while also accelerating their review process by the FDA.</li><li>As a result of this designation, Cocrystal will be able to communicate more frequently and earlier with the FDA throughout the development of CDI-988.</li><li>The company stated that this will also allow for a rolling review of a New Drug Application.</li></ul>Cocrystal Pharma Inc. (COCP) stock soared more than 75% in Thursday’s pre-market trade after the company’s norovirus infection treatment received Fast Track designation from the U.S. Food and Drug Administration (FDA).Cocrystal stated that the Fast Track designation for CDI-988 allows for the treatment’s accelerated development and expedited regulatory review.<h2 class="st-heading-2">Why Is Fast Track Designation Important For CDI-988?</h2>Cocrystal stated that the Fast Track designation is aimed at facilitating the development of drugs that treat serious conditions and address unmet medical needs, while also accelerating their review process by the FDA.As a result of this designation, Cocrystal will be able to communicate early and more frequently with the FDA throughout the development of CDI-988. The company stated that this will also allow for a rolling review of a New Drug Application (NDA).CDI-988 may also qualify for Priority Review at the time of NDA submission.“We are pleased that the FDA has granted Fast Track designation for CDI-988, marking a significant milestone for Cocrystal and a critical step toward helping patients with norovirus,” said Cocrystal’s co-CEO, Sam Lee.Lee added that based on the data generated for CDI-988 so far, the company expects the treatment to potentially prevent as well as treat the norovirus infection.<h2 class="st-heading-2">Is Norovirus Infection A Serious Condition?</h2>Norovirus is a highly contagious virus that causes acute gastroenteritis. The infection can be serious due to rapid dehydration and is particularly dangerous for young children and the elderly.“While most people recover within a few days, immunocompromised individuals can experience chronic, long-term norovirus infections that can persist for weeks to years,” Lee added.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/COCP">Cocrystal Pharma</a> trended in the ‘bullish’ territory at the time of writing, with message volumes at ‘extremely high’ levels.One bullish user on the platform termed the FDA Fast Track designation as a “big pharma type news for less than $5.”<stembedurl>https://stocktwits.com/cjstocksup/message/649279769</stembedurl><a href="https://stocktwits.com/symbol/COCP">COCP stock</a> is up 4% year-to-date, but down 28% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 17% over the past 12 months, while the Vanguard Extended Market Index Fund ETF (VXF) is up 20%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-china-made-ev-sales-march-2026/cZ7xoOYRI8R">Tesla’s China-Made EV Sales Rise 9% In March, Registering Fifth Straight Month Of Gains: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment?

Cocrystal stated that the Fast Track designation for CDI-988 enables accelerated development and expedited regulatory review.

<ul class="summary-bullets"><li>Alto will now focus on its other programs including ALTO-207 in development for treatment -resistant depression.</li><li>The company said that it also intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed.</li></ul>Shares of Alto Neuroscience, Inc. (ANRO) fell as much as 10% after hours on Wednesday after the company said that its experimental drug for the treatment of schizophrenia failed to achieve statistical significance on key goals in a mid-stage study.The company was studying ALTO-101 for the treatment of cognitive impairment associated with schizophrenia. However, no statistically significant changes were detected on primary electroencephalography or cognitive endpoints as compared to placebo, the company said.<h2 class="st-heading-2">Plans Ahead</h2>As a result, the company does not intend to independently advance ALTO-101 in CIAS anymore, it said, while adding that it would now focus on its other programs including ALTO-207 in development for treatment -resistant depression. Alto is looking to initiate a mid-stage trial for &nbsp;ALTO-207 in the first half of 2026. &nbsp;The company said that it now intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed. The formulation has demonstrated an improved pharmacokinetic and tolerability profile when compared to the immediate-release formulation, Alto said, while adding that it believes the formulation may offer potential benefits across several therapeutic areas.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ANRO &nbsp;stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.A Stocktwits user noted the company’s balance sheet, terming it an “easy short.”<stembedurl>https://www.stocktwits.com/Shortski/message/649224122</stembedurl>The company said earlier this month that it had cash, cash equivalents, and restricted cash of approximately $177 million as of the end of 2025, expected to support its planned operations into 2028.Another user termed the selloff an “overreaction.”<stembedurl>https://www.stocktwits.com/RazorbackAJ/message/649224026</stembedurl> <a href="https://stocktwits.com/symbol/ANRO">ANRO stock</a> has gained 32% this year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-agpu-stock-rise-today/cZ7HyVtRIF0">Why Did AGPU Stock Rise 120% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Alto Neuroscience logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ANRO Stock Falls After Hours On Failed Schizophrenia Study Results

Alto Neuroscience does not intend to independently advance ALTO-101 in CIAS anymore, it said. 

<ul class="summary-bullets"><li>New Era Energy added that the TCDC project is expected to be structured through a newly formed Delaware limited liability company.</li><li>The project’s financing will be led by an unnamed institutional investor, with debt accounting for about 80% of the funding, it said.</li><li>New Era Energy stated that its equity position in the venture is expected to generate distributions from operating cash flow after commercial operations of the first phase commence.</li></ul>New Era Energy &amp; Digital Inc. (NUAI) shares gained nearly 6% in Wednesday’s opening trade after the company announced a partnership for its flagship Texas data center facility.New Era Energy stated that it has entered into a non-binding letter of intent (LOI) to form a joint venture with Stream Data Centers for the development and financing of the company’s Texas Critical Data Centers (TCDC) facility in West Texas.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/NUAI">New Era Energy</a> trended in the ‘bearish’ territory at the time of writing.<h2 class="st-heading-2">Stream To Develop And Manage NUAI’s Facility</h2>New Era Energy stated that Stream will develop and manage the company’s data center facility, while leveraging the former’s local relationships.It added that the TCDC project is expected to be structured through a newly formed Delaware limited liability company. The project’s financing will be led by an unnamed institutional investor, with debt accounting for about 80% of the funding.The company added that its equity position in the venture is expected to generate distributions from operating cash flow after commercial operations of the first phase commence, providing a near-term path to recurring revenue.“This LOI represents an important step in advancing TCDC toward delivery, and we remain focused on progressing toward a definitive agreement with Stream,” said New Era Energy CEO E. Will Gray II.He added that the company expects to invest in the project alongside its partner amid a growing need for purpose-built, power-ready data center infrastructure.<h2 class="st-heading-2">TCDC Campus Spread Across 438 Acres</h2>New Era Energy’s TCDC campus is located in the Permian Basin of West Texas. The campus is spread across 438 acres owned by the company, with an additional 54-acre corridor that is currently pending approval.The TCDC campus is designed for a total capacity of over a gigawatt, with the expansion planned across three phases. The first phase will kick off with 200 megawatt capacity, while the second phase will add another 450 MW capacity. New Era Energy states that it will utilize utility-sourced power and on-site gas-fired energy in these two phases.The third phase is expected to take the total capacity to over a gigawatt. The company has projected that power delivery will be achieved by the end of 2027.In January 2026, New Era Energy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-nuai-stock-falling-today/cmyR4nVR4gX">announced</a> plans to raise up to $350 million to fund acquisitions, pay or refinance debt, meet capital expenditures, and other working capital requirements.<h2 class="st-heading-2">How Did Retail Traders React?</h2>One user stated that the partnership announced on Wednesday removes one of the biggest question marks for the company going forward.<stembedurl>https://stocktwits.com/roiger/message/649150963</stembedurl>Another user stated that this is big news for New Era Energy, adding that the company is “completely derisked now.”<stembedurl>https://stocktwits.com/YoloAlfred/message/649150643</stembedurl><a href="https://stocktwits.com/symbol/NUAI">NUAI stock</a> is up 39 % year-to-date and 256% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 17% over the past 12 months, while the Vanguard Extended Market Index Fund ETF (VXF) is up 20%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-tumbles-q4-outlook-china-weakness-nike-stock-downgrade-pt-cuts/cZ7HkFpRInM">Nike’s China Bet Is Under Pressure And Wall Street Is Losing Confidence – Analysts Warn Return To Growth Could Take 4 Quarters</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Computer racks in Data Center (Representative image courtesy of Arctic-Images via Getty Images)

Why Is NUAI Stock Rising Today? A Texas Data Center Deal Could Be Key

New Era Energy stated that it has entered into a non-binding letter of intent to form a joint venture with Stream Data Centers to develop and finance the facility.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

VTI
Vanguard Total Stock Market ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VTI News

VTIVanguard Total Stock Market ETF